About Profound Medical
Profound Medical is a company based in Toronto (Canada) founded in 2008. Profound Medical has raised $37.73 million across 12 funding rounds from investors including Stifel, BDC and Cormark Securities. The company has 142 employees as of December 31, 2024. Profound Medical offers products and services including TULSA-PRO and Sonalleve. Profound Medical operates in a competitive market with competitors including Insightec, HistoSonics, Theraclion, Carthera and SONIRE Therapeutics, among others.
- Headquarter Toronto, Canada
- Employees 142 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Profound Medical Corp
-
Annual Revenue
$10.17 M (USD)50.58as on Dec 31, 2024
-
Net Profit
-$26.49 M (USD)0.31as on Dec 31, 2024
-
EBITDA
-$30.59 M (USD)-17.63as on Dec 31, 2024
-
Total Equity Funding
$37.73 M (USD)
in 12 rounds
-
Latest Funding Round
$6.45 M (USD), Post-IPO
Dec 19, 2025
-
Investors
Stifel
& 7 more
-
Employee Count
142
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Profound Medical
Profound Medical is a publicly listed company on the TSX with ticker symbol PRN in Canada, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Profound Medical
Profound Medical offers a comprehensive portfolio of products and services, including TULSA-PRO and Sonalleve.
Device for MRI-guided ablation of prostate tissue in cancer treatment.
System for focused ultrasound interventions in various therapies.
People of Profound Medical
Unlock access to complete
Unlock access to complete
Funding Insights of Profound Medical
Profound Medical has successfully raised a total of $37.73M across 12 strategic funding rounds. The most recent funding activity was a Post-IPO round of $6.45 million completed in December 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Profound Medical
Profound Medical has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Stifel, BDC and Cormark Securities.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage life sciences companies are supported through venture capital investments.
|
Locked | Locked | Locked | |
|
Prescription pharmaceuticals are acquired, licensed, and commercialized by the company.
|
Locked | Locked | Locked | |
|
Diversified investment management services are provided globally.
|
Locked | Locked | Locked |
Investor details for Profound Medical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Profound Medical
Investment portfolio details for Profound Medical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Profound Medical
Detailed financials for Profound Medical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Profound Medical Comparisons
Peer comparison for Profound Medical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Profound Medical
Profound Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insightec, HistoSonics, Theraclion, Carthera and SONIRE Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
MR-interfaced ultrasound devices for cancer and neurology treatments are provided.
|
|
| Locked | Locked | Locked |
Tissue ablation is achieved through non-invasive ultrasound Histotripsy technology.
|
|
| Locked | Locked | Locked |
Provider of non-invasive robotic ultrasound therapy devices
|
|
| Locked | Locked | Locked |
Ultrasound-based medical devices for brain tumor treatment are developed.
|
|
| Locked | Locked | Locked |
High-intensity focused ultrasound systems for targeted cancer treatments are developed.
|
Detailed competitors of Profound Medical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Profound Medical
Complete news archive for Profound Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Profound Medical
Profound Medical was founded in 2008.
Profound Medical is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
Profound Medical is a funded company, having raised a total of $37.73M across 12 funding rounds to date.
As of Dec 31, 2024, the latest employee count at Profound Medical is 142.
Annual revenue of Profound Medical is $10.17M as on Dec 31, 2024.
Profound Medical was founded in 2008 in Toronto, Canada, within the medical technology sector focused on oncology. Image-guided ablation systems for prostate cancer treatment are developed and provided by the company. Proprietary technology is utilized in the TULSA-PRO system, an AI-powered, MRI-guided, incision-free robotic platform designed for precise ablation of prostate tissue. Operations center on advancing non-invasive therapeutic solutions for urological conditions.
Profound Medical's top competitors include Insightec, HistoSonics and Theraclion.
Profound Medical offers TULSA-PRO and Sonalleve.
Yes, Profound Medical is publicly traded on TSX under the ticker symbol PRN.
Profound Medical has 8 investors. Key investors include Stifel, BDC, Cormark Securities, Knight Therapeutics, and Bloom Burton & Co.
The ticker symbol of Profound Medical is PRN on TSX.